Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
In 2006, the US Food and Drug Administration (FDA) approved intravitreal injections of anti-vascular endothelial growth factor inhibiting drugs for the treatment of nAMD.2,3 These new treatment strategies of intraocular injections resulted in unprecedented visual acuity gains in eyes that, in the past, have experienced relentless vision loss despit...
Alternative Titles
Full title
Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2955266518
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2955266518
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(24)00229-0
